CirQlight

About

CIRQLIGHT ™ ®: AN INNOVATIVE MONO-CHROMATIC WEARABLE GARMENT, DESIGNED TO ENHANCE BLOOD CIRCULATION AND IMPROVE ‘COLD FEET SYNDROME’, POOR CIRCULATION, LEG TRAUMA, POST SURGERY, HEALING, LYMPHEDEMA, ECZEMA, DERMATITIS, INSECT BITE SYMPTOMS REDUCTION, SKIN REJUVENATION We, at CosmoAesthetics, have designed a patent wearable garment Vibro-LED technology that, is a simply battery-operated device that can be simply used by the patient to manage pain, swelling and joint stiffness at home. LED uses a low-level light technology known as LLLT, which uses a proven scientific wavelength that can deliver specific rays of light to its target, being bone, muscle, and tissue and reduce pain and inflammation, as early as the first session of 10 min use. It is non-invasive, drug-free, safe, affordable, with zero side effects! Oedema is a term associated with swelling caused due to infection or inflammation of tissues. It occurs when small blood vessels leak fluids, which are stored in surrounding tissues leading to swelling. Oedema can be caused due injury, pregnancy, certain heart, kidney or liver disease, and cerebral oedema. CirQLight is also equipped with an artificial intelligence software that can measure patient's joint healing and body movement rate to communicate with the physician or health insurance provider for better tracking of their pain improvement, joint flexibility, and enhanced wellness, post-surgery, post-trauma or aging-related illnesses. Medications such as NSAIDs, calcium channel blockers, and corticosteroids used to treat certain diseases can also cause oedema. Treatment lies in the understanding of the underlying cause of edema. Mild oedema can be cured, without any medication, by raising the affected limb higher than the heart. Severe oedema, however, is treated with drugs that help rid the body of excess fluid in the form of urine. An increase in occurrences of cardiac, kidney, and liver diseases is the major factor driving the oedema treatment market. Macular edema is higher in diabetes type-2 patients. Due to lifestyle and diet, diabetes and heart disease are very common leading to rising in edema patients. Additionally, continuous research supported by substantial R&D investments by large pharmaceutical companies and advancement in health care technologies is the major factors fuelling the growth of the global edema treatment market. According to NewsWire, the global leg-symptoms related treatment market (2016-2022 ) can reach 18.3 USD Billion dollars with an estimate of 3.2% annual increase CAGR. However, according to the Australian Institute of Health & Welfare, 29% of Australian suffer from Musculoskeletal disease. Arthritis is the second most common cause of disability and early retirement due to ill health, costing $1.1 billion a year in extra welfare payments and lost taxation revenue, as well as $7.2 billion in lost GDP.